JOHN YATES, M.D., is president of Takeda Global Research and Development Center Inc. Previously, he served as vice president, Medical and Scientific Affairs (MEDSA) of Merck & Co. Prior to joining MEDSA, Dr.Yates was vice president of clinical development in the U.S. Human Health Division of Merck. He also worked with the then-nascent osteoporosis clinical research team at Merck and subsequently led that team in the development of bisphosphonate alendronate (Fosamax) for treatment and prevention of postmenopausal osteoporosis.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement